IOVA Iovance Biotherapeutics Chart, History Price & Graph

Key Takeaways

• IOVA exhibits a positive long-term trend with the price trading well above the 200-day moving average near $2.70, while short-term momentum remains neutral amid consolidation.
• Key support cluster around $3.42–$3.63, with immediate resistance at $3.88–$4.04.
• RSI(14) at approximately 54, indicating neutral momentum; MACD shows a slight positive reading of 0.02 but with mixed signals.
• Price positioned in the middle of its recent one-month range ($3.18–$4.31), with reduced volatility and average daily volume around 16 million shares.
• Stochastics neutral near 55%, reflecting balanced buying and selling pressure.

Trend Analysis

The chart of Iovance Biotherapeutics (IOVA) reveals a bullish long-term structure, supported by significant price appreciation over the past 200 days (+114%) and year-to-date gains. However, short-term price action has shifted to neutral, with the stock consolidating after recent volatility. It trades above major longer-term moving averages but below shorter-term ones like the 5-day and 20-day SMAs, forming a potential basing pattern amid lower volatility (ATR around 7.8%). This setup suggests stabilization following prior upside momentum, with relative strength outperforming 79% of peers.

Moving Averages

Key moving averages underscore the divergent trends. The 50-day SMA stands at $3.64 and the 200-day at $2.70, confirming a bullish alignment as shorter MAs remain above the long-term average—a classic golden cross formation. Nearer-term, the 20-day SMA is $3.61 and 5-day at $3.80, with IOVA hovering just below these levels. Price changes reflect strength over 50-day (+48%) and 100-day (+50%) periods, supporting the intermediate uptrend despite short-term pullbacks.

Momentum Indicators

Momentum oscillators present a balanced picture. The RSI(14) reading of 54.54 signals neither overbought nor oversold conditions, consistent across sources at neutral levels around 50–55. MACD (12,26) registers at 0.02, positive yet declining, hinting at waning upside momentum in the short term. Stochastics %K and %D hover around 54–55 for 14- and 20-day periods, reinforcing equilibrium. Low ADX values (15–22) indicate weak trend strength, aligning with the consolidation phase.

Support and Resistance Levels

Traders eye pivotal zones for directional cues. Immediate support lies at $3.72 (S1), $3.63 (S2), and $3.56 (S3), with deeper levels at $3.42 (weekly) and $3.29 (daily). Resistance starts at $3.88 (R1), $3.95 (R2), and $4.04 (R3), followed by $4.02 (daily) and a weekly barrier near $4.52. A 3.56–3.64 zone acts as near-term resistance, where prior consolidation has occurred. Breaks beyond these could signal trend resumption.

Volume and Market Activity

Trading volume averages 16.4 million shares daily, with recent sessions showing a decline to around 14 million, indicative of reduced participation during consolidation. This lower volume supports the view of a pause rather than aggressive selling, as price holds above key supports without spike downside volume.

AI Daily Buy/Sell Signals

Tickeron’s AI Daily Buy/Sell Signals leverage artificial intelligence to scrutinize vast arrays of market data, technical indicators, and historical price patterns, generating actionable buy or sell signals for stocks like IOVA. These signals draw from trend recognition, momentum shifts, and pattern matching to highlight potential entry and exit opportunities. Traders rely on them to validate chart setups, gauge trend strength, and refine decision-making amid volatility. By automating complex analysis, the AI provides timely insights that complement manual review. Explore the signals to see how they align with IOVA’s current technical profile.

Technical Outlook and Key Levels to Watch

Market participants monitor breaks from consolidation for trend clarification. A hold above $3.60 support could target resistance at $3.88–$4.04, while failure might test $3.42. Watch RSI for divergences, MACD crossovers, and volume surges to confirm moves. Moving average alignments and pivot adherence remain focal points in this biotech name’s volatile framework.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.